RT-qPCR analysis indicated that mRNA expression of G6Pase, a critical gluconeogenic enzyme, was significantly decreased in T2DM mice but increased after both HUCMSCs and combination treatments (** p < 0.01; Figure 7A). The gene discussed is G6PC1; the disease is type 2 diabetes mellitus.